Doyle Alicia, Pollack Mark H
Center for Anxiety and Traumatic Stress Related Disorders, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA.
J Clin Psychiatry. 2004;65 Suppl 5:24-8.
Panic disorder is a chronic, disabling condition that is often associated with a need for long-term clinical treatment. While a variety of pharmacotherapy options, including tricyclic antidepressants, selective serotonin reuptake inhibitors, and benzodiazepines, are effective in reducing symptoms in the acute phase, a significant number of patients do not fully respond to initial treatment, and a large majority of patients experience relapse after medication discontinuation. Optimal long-term treatment of panic disorder involves attention to adequate medication dosing and adequate duration of treatment to achieve maximum improvement before discontinuing. Recent reports suggest the efficacy of adjunctive pharmacotherapies and combining pharmacotherapy with behavioral therapy to improve treatment response. Further research is necessary to determine the long-term effectiveness of these multifaceted treatment strategies among patients suffering from refractory panic disorder.
惊恐障碍是一种慢性致残性疾病,通常需要长期临床治疗。虽然包括三环类抗抑郁药、选择性5-羟色胺再摄取抑制剂和苯二氮䓬类药物在内的多种药物治疗方案在急性期可有效减轻症状,但相当多的患者对初始治疗反应不完全,并且绝大多数患者在停药后会复发。惊恐障碍的最佳长期治疗需要注意给予足够的药物剂量和足够的治疗时长,以便在停药前实现最大程度的改善。最近的报告表明辅助药物治疗以及将药物治疗与行为疗法相结合可提高治疗反应。有必要进一步研究这些多方面治疗策略对难治性惊恐障碍患者的长期有效性。